Free Trial

Valerie A. Mitchell Sells 548 Shares of NCS Multistage Holdings, Inc. (NASDAQ:NCSM) Stock

NCS Multistage logo with Energy background

Key Points

  • Director Valerie A. Mitchell sold 548 shares of NCS Multistage Holdings, Inc. for a total value of $16,440, reducing her ownership by 2.10% to 25,520 shares valued at approximately $765,600.
  • NCS Multistage reported earnings of **$0.34 per share**, significantly beating analysts' estimates and achieving a revenue of **$36.45 million** for the latest quarter.
  • Following strong earnings, Wall Street Zen upgraded NCS Multistage from a "buy" to a **"strong-buy"** rating, indicating increased investor confidence.
  • Need Better Tools to Track NCS Multistage? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

NCS Multistage Holdings, Inc. (NASDAQ:NCSM - Get Free Report) Director Valerie A. Mitchell sold 548 shares of the firm's stock in a transaction on Monday, August 4th. The stock was sold at an average price of $30.00, for a total transaction of $16,440.00. Following the transaction, the director directly owned 25,520 shares of the company's stock, valued at approximately $765,600. This represents a 2.10% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

NCS Multistage Stock Performance

Shares of NASDAQ:NCSM traded down $1.09 on Friday, hitting $32.79. The company's stock had a trading volume of 6,714 shares, compared to its average volume of 9,120. The company has a market capitalization of $83.29 million, a price-to-earnings ratio of 6.87 and a beta of 0.71. The stock's 50-day moving average is $30.58 and its two-hundred day moving average is $30.27. NCS Multistage Holdings, Inc. has a 12 month low of $16.81 and a 12 month high of $38.95. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.86 and a current ratio of 4.66.

NCS Multistage (NASDAQ:NCSM - Get Free Report) last announced its earnings results on Thursday, July 31st. The company reported $0.34 earnings per share for the quarter, beating the consensus estimate of ($1.46) by $1.80. NCS Multistage had a return on equity of 12.50% and a net margin of 7.18%. The business had revenue of $36.45 million during the quarter, compared to analysts' expectations of $27.60 million.

Hedge Funds Weigh In On NCS Multistage

Hedge funds have recently modified their holdings of the stock. Bailard Inc. purchased a new stake in shares of NCS Multistage in the first quarter worth approximately $249,000. Geode Capital Management LLC bought a new stake in shares of NCS Multistage during the 4th quarter worth $247,000. Renaissance Technologies LLC bought a new stake in NCS Multistage during the fourth quarter valued at about $261,000. Dimensional Fund Advisors LP grew its holdings in NCS Multistage by 14.1% in the 4th quarter. Dimensional Fund Advisors LP now owns 13,679 shares of the company's stock valued at $355,000 after buying an additional 1,689 shares during the last quarter. Finally, Empowered Funds LLC grew its stake in shares of NCS Multistage by 7.3% in the first quarter. Empowered Funds LLC now owns 21,489 shares of the company's stock worth $752,000 after acquiring an additional 1,455 shares during the last quarter. 70.91% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Separately, Wall Street Zen raised NCS Multistage from a "buy" rating to a "strong-buy" rating in a report on Saturday, June 7th.

Get Our Latest Report on NCSM

About NCS Multistage

(Get Free Report)

NCS Multistage Holdings, Inc provides engineered products and support services for oil and natural gas well completions and construction, and field development strategies in the United States, Canada, and internationally. It offers fracturing systems, which include casing-installed sliding sleeves, downhole frac isolation assemblies, and sand jet perforating products; enhanced recovery products, such as sliding sleeve, as well as Terrus system, an injection control device; repeat precision products comprising composite frac plugs and bridge plugs, single-use disposable setting tools, express systems, and related products; chemical and radioactive tracer diagnostics services; and well construction products, including AirLock casing buoyancy system, Vecturon and Vectraset liner hanger systems, and Toe initiation sleeves.

Featured Articles

Should You Invest $1,000 in NCS Multistage Right Now?

Before you consider NCS Multistage, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NCS Multistage wasn't on the list.

While NCS Multistage currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Buy-the-Dip Stocks Poised to Rebound Soon
Quantum Boom: 3 Strong Picks with Lower Risk
3 Overlooked AI Stocks That Chipmakers Can’t Live Without

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines